We further used RT-qPCR to validate their differential expression in various NB cell lines such as MYCN amplified (SK-N-BE(2)-C, SK-N-DZ) and MYCN non-amplified (SK-N-AS, SK-N-F1, SK-N-SH). This evidence concerns the gene MYCN and neuroblastoma.